Robert Olstein
Olstein Capital Management
Robert Olstein Johnson & Johnson stake
total: 342
Olstein Capital Management JNJ trades
- Total transactions:
- 28
- New positions:
- 2
- Sold out:
- 2
- Added:
- 9
- Reduced:
- 15
- Held since:
- 2020 Q2
- Held for:
- 24 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Robert Olstein doesn't hold any Johnson & Johnson (JNJ) shares. Olstein Capital Management has held JNJ since at least 2013 Q2 with 90,000 shares in our earliest available record. Robert Olstein later completely sold out the position and invested in Johnson & Johnson again in 2020 Q2. Since at least 2013 Q2, Olstein Capital Management has made 27 more transactions.
When did Robert Olstein sell Johnson & Johnson (JNJ)?
Robert Olstein sold off the entire Johnson & Johnson (JNJ) position in 2026 Q2.
Estimated cost basis*
- Weighted AVG buy price:
- $153.21
- Weighted AVG sell price:
- $206.11
Robert Olstein's historical trades in Johnson & Johnson
28 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.00%
|
0
|
$244.45
|
|
-100% (-24,500)
|
-1.31%
|
|
2026 Q1
|
1.31%
|
24,500
|
$244.45
|
$5,989,000
|
-15.52% (-4,500)
|
-0.23%
|
|
2025 Q4
|
1.23%
|
29,000
|
$206.97
|
$6,002,000
|
-40.21% (-19,500)
|
-0.76%
|
|
2025 Q3
|
1.70%
|
48,500
|
$185.42
|
$8,993,000
|
-20.49% (-12,500)
|
-0.43%
|
|
2025 Q1
|
1.86%
|
61,000
|
$165.84
|
$10,116,000
|
-6.15% (-4,000)
|
-0.12%
|
|
2024 Q4
|
1.65%
|
65,000
|
$144.62
|
$9,400,000
|
+6.56% (+4,000)
|
+0.1%
|
|
2024 Q2
|
1.59%
|
61,000
|
$146.16
|
$8,916,000
|
+1.67% (+1,000)
|
+0.03%
|
|
2023 Q1
|
1.46%
|
60,000
|
$155.00
|
$9,300,000
|
+25.00% (+12,000)
|
+0.29%
|
|
2022 Q4
|
1.33%
|
48,000
|
$176.65
|
$8,479,000
|
-17.24% (-10,000)
|
-0.3%
|
|
2022 Q3
|
1.59%
|
58,000
|
$163.36
|
$9,475,000
|
-4.92% (-3,000)
|
-0.07%
|
|
2022 Q2
|
1.62%
|
$177.51
|
-14.08% (-10,000)
|
|||
|
2021 Q4
|
1.45%
|
$171.07
|
+10.94% (+7,000)
|
|||
|
2021 Q1
|
1.47%
|
$164.34
|
+42.22% (+19,000)
|
|||
|
2020 Q4
|
1.13%
|
$157.38
|
+32.35% (+11,000)
|
|||
|
2020 Q3
|
0.92%
|
$148.88
|
+30.77% (+8,000)
|
|||
|
2020 Q2
|
0.68%
|
$140.62
|
new
|
|||
|
2017 Q2
|
0.00%
|
$124.55
|
-100% (-29,000)
|
|||
|
2016 Q4
|
0.43%
|
$115.21
|
-3.33% (-1,000)
|
|||
|
2016 Q3
|
0.47%
|
$118.13
|
-26.83% (-11,000)
|
|||
|
2016 Q2
|
0.67%
|
$121.29
|
-18.00% (-9,000)
|
|||
|
2016 Q1
|
0.72%
|
$108.20
|
-29.58% (-21,000)
|
|||
|
2014 Q4
|
0.91%
|
$104.56
|
-14.46% (-12,000)
|
|||
|
2014 Q3
|
1.15%
|
$106.59
|
-4.60% (-4,000)
|
|||
|
2014 Q2
|
1.23%
|
$104.62
|
-20.91% (-23,000)
|
|||
|
2014 Q1
|
1.48%
|
$98.23
|
+20.88% (+19,000)
|
|||
|
2013 Q4
|
1.19%
|
$91.59
|
-1.09% (-1,000)
|
|||
|
2013 Q3
|
1.22%
|
$86.68
|
+2.22% (+2,000)
|
|||
|
2013 Q2
|
1.24%
|
$85.86
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.